论文部分内容阅读
目的探讨肺心病合并冠心病心衰采用低分子肝素钠与硝酸甘油联合治疗临床效果。方法选取肺心病与冠心病心衰合并发生的患者80例,随机分组,就西药常规治疗(对照组,n=40)与低分子肝素钠与硝酸甘油联合治疗(观察组,n=40)效果展开对比。结果观察组选取的肺心病与冠心病合并心衰的病例临床总有效率为95%,明显高于对照组70%,差异有统计学意义(P<0.05)。观察组有轻微恶心、头晕、头痛4例,对照组3例,组间比较无明显差异(P>0.05)。结论慢性肺心病与冠心病心衰合并发生的患者,采用低分子肝素钠与硝酸甘油联合治疗,可显著提高临床治疗效果,且安全性居较高水平。
Objective To investigate the clinical effect of combined treatment of low molecular weight heparin and nitroglycerin on patients with cor pulmonale complicated with heart failure. Methods Eighty patients with pulmonary heart disease and coronary heart disease complicated with heart failure were randomly divided into two groups: control group (n = 40) and low molecular weight heparin combined with nitroglycerin (observation group, n = 40) Contrast Results The total clinical effective rate of cor pulmonale and coronary heart disease with heart failure was 95% in observation group, which was significantly higher than that in control group (P <0.05). The observation group had mild nausea, dizziness, headache in 4 cases and control group in 3 cases. There was no significant difference between the two groups (P> 0.05). Conclusion Chronic pulmonary heart disease and coronary heart disease complicated with heart failure patients with low molecular weight heparin sodium and nitroglycerin combination therapy can significantly improve the clinical efficacy and safety at a high level.